Short, Nicholas J.
Kantarjian, Hagop
Kanagal-Shamanna, Rashmi http://orcid.org/0000-0001-7829-5249
Sasaki, Koji
Ravandi, Farhad
Cortes, Jorge
Konopleva, Marina
Issa, Ghayas C. http://orcid.org/0000-0002-4339-8683
Kornblau, Steven M. http://orcid.org/0000-0002-5990-9548
Garcia-Manero, Guillermo
Garris, Rebecca
Higgins, Jake
Pratt, Gabriel
Williams, Lindsey N.
Valentine, Charles C. III
Rivera, Victor M.
Pritchard, Justin
Salk, Jesse J.
Radich, Jerald
Jabbour, Elias
Article History
Received: 25 March 2020
Revised: 29 April 2020
Accepted: 5 May 2020
First Online: 26 May 2020
Conflict of interest
: N.J.S. reports consulting fees from Takeda Oncology and AstraZeneca, research funding from Takeda Oncology and Astellas Pharma Inc., and honoraria from Amgen. F.R. reports research funding from Bristol-Myers Squibb and honoraria from Bristol-Myers Squibb, Novartis and Pfizer. J.H., G.P., L.N.W., C.C.V., and J.J.S. are employees and equity holders of TwinStrand Biosciences Inc., which performed Duplex Sequencing. V.M.R. reports employment, stock, and other ownership interests in ARIAD Pharmaceuticals Inc. The other authors report no relevant conflict of interest.